Biogen Inc. - Company & Market Research Reports

Home /
Companies /
Biogen Inc.

Founded in 1978 Biogen Inc is a global biotechnology company with its headquarters in Cambridge, Massachusetts. In 2003 Biogen merged with Idec Pharmaceuticals to create Biogen Idec and acquired Syntonix Pharmaceuticals in 2007. In 2015 the company returned to its original name Biogen Inc and acquired Convergence Pharmaceuticals. Biogen focuses on drug discovery for a range of conditions including neuropathic pain, hemophilia, organ failure, neuromuscular disorders and oncology. Their product portfolio includes Rituxan, Avonex, Tecfidera and Eloctate.

REFINE BY

KEYWORD

CATEGORIES

Central Nervous System Drugs 154
Genomics 73
Biopharmaceuticals 73
Immune Disorders Drugs 71
Biotechnology 50
Pharmaceuticals 42
Oncology Drugs 41
Musculoskeletal Disorders Drugs 41
Drug Discovery 37
Hematological Drugs 36
Biosimilars and Biosuperiors 31
Alzheimer's Disease Drugs 26
Infusions and Injectables 25
Cardiovascular Drugs 24
Allergy and Immunology 22
Clinical Trials 22
Optical Disorders Drugs 21
Mental Disorders Drugs 19
Neurology 17
Needles and Syringes 17
E-Healthcare 14
Respiratory Drugs 14
Psoriasis Drugs 14
Infectious Diseases Drugs 12
Optical 12
Immunosuppressive Drugs 12
Healthcare Services 11
Hematology 11
Gastrointestinal Drugs 11
Pharmaceutical Manufacturing 11
Drug Delivery 10
Drugs by Therapeutic Area 9
Lymphoma Drugs 9
Analgesics 9
Diagnostics 9
Endocrine and Metabolic Disorders Drugs 9
Therapeutic Area 8
Leukemia Drugs 8
Pulmonary Medicine 7
Liver and Kidney Disorders Drugs 7
Enzymes 5
Medical Devices 5
Oncology 5
Schizophrenia Drugs 5
Company Reports 4
Proteomics 4
Mental Health 4
Neurology Devices 4
Cardiology 4
Pharmaceutical Intermediates 3
Generic Drugs 3
Stem Cells 3
Hospital Management 3
Dermatology 3
Vitamins and Dietary Supplements 3
Gastroenterology 3
Dermatological Drugs 3
Urology and Nephrology 2
Pharmacoeconomics 2
Prostate Cancer Drugs 2
In Vitro Diagnostics 2
Managed Care 2
Diabetes Devices 2
Biomaterials 2
Biomarkers 2
Vaccines 2
Skin Cancer Drugs 2
Laboratory Equipment 2
Pediatrics 2
Anxiety Drugs 2
Addiction Disorders Drugs 1
Diabetes Drugs 1
Women's Health 1
Fertility Services 1
Lung Cancer Drugs 1
Colon Cancer Drugs 1
Cervical Cancer Drugs 1
Brain Cancer Drugs 1
Medical Imaging 1
Infectious Disease Testing 1
Transdermal and Transmucosal Drug Delivery 1
Contrast Media 1
Kidney Cancer Drugs 1
Nanomedicine 1
Antibiotics 1
Clinical Skills 1
Anatomy 1
Endocrinology 1
Allergy Drugs 1
Asthma Drugs 1
Sexual and Reproductive Health Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



281 reviews

855 Results (Page 7 of 43)
- Relevance
  Sort by

Alpha 1 Antitrypsin Deficiency Treatment - Global Strategic Business Report

 Report
December 2025
196 Pages
Global

From

€5152EUR$5,850USD£4,529GBP

Digital Biomarkers Market Size, Share & Trends Analysis Report By Type (Wearable, Mobile Based Applications), By Clinical Practice, By Therapeutic Area, By End-use (Healthcare Companies), By Region, And Segment Forecasts, 2024 - 2030

 Report
July 2024
150 Pages
Global

From

€5240EUR$5,950USD£4,606GBP

Cell and Gene Therapy CRO Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Cell Therapy, Type of Genetic Modification, Stage of Development, Therapeutic Area, End-users and Key Geographical Regions

 Report
June 2025
343 Pages
Global

From

€4227EUR$4,799USD£3,715GBP

Formulation Development Outsourcing Market Size, Share & Trends Analysis Report by Service (Preformulation, Formulation Development), Formulation, Therapeutic Area, End-use, Region, with Growth Forecasts, 2025-2030

 Report
April 2025
120 Pages
Global

From

€5240EUR$5,950USD£4,606GBP

Central Nervous System Biomarkers - Global Strategic Business Report

 Report
December 2025
376 Pages
Global

From

€5152EUR$5,850USD£4,529GBP

NEED HELP FINDING THE RIGHT PRODUCT? Olha will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Cutaneous Lupus Erythematosus - Market Insight, Epidemiology And Market Forecast - 2032

 Report
April 2023
164 Pages
Global

From

€6694EUR$7,600USD£5,884GBP

€8367EUR$9,500USD£7,355GBP

Alzheimer's Disease: 68-Market Analysis and Sales Forecast - Update

 Report
August 2025
19 Pages
Global

From

€15849EUR$17,995USD£13,932GBP

Alzheimer's Disease: Eight-Market Drug Forecast and Market Analysis - Update

 Report
August 2025
160 Pages
Global

From

€15849EUR$17,995USD£13,932GBP

Psychiatric Digital Biomarkers Market - Global Strategic Business Report

 Report
December 2025
386 Pages
Global

From

€5152EUR$5,850USD£4,529GBP

Bone Marrow Transplant Rejection Treatment Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
May 2023
93 Pages
Global

From

€3500EUR$4,257USD£3,184GBP

Pediatric Epilepsy Therapeutics - Global Strategic Business Report

 Report
December 2025
184 Pages
Global

From

€5152EUR$5,850USD£4,529GBP

Next Generation Antibody Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

 Report
January 2024
106 Pages
Global

€4399EUR$4,995USD£3,867GBP

Connective Tissue Diseases - Global Strategic Business Report

 Report
December 2025
385 Pages
Global

From

€5152EUR$5,850USD£4,529GBP

Skeletal Dysplasia Market - Global Strategic Business Report

 Report
December 2025
378 Pages
Global

From

€5152EUR$5,850USD£4,529GBP

Fertility Drugs Market Report 2025

 Report
April 2025
175 Pages
Global

From

€3955EUR$4,490USD£3,476GBP

Companion Diagnostic Collaboration and Licensing Deals 2010-2025

 Report
November 2025
300 Pages
Global

From

€3519EUR$3,995USD£3,093GBP

Alzheimer's Disease Treatment Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Product Type

 Report
November 2024
89 Pages
Global

From

€3500EUR$4,257USD£3,184GBP

Myasthenia Gravis Treatment Market: Forecast and Trends

 Report
November 2023
120 Pages
Global

From

€4096EUR$4,650USD£3,600GBP

Non-Opioid Therapeutics Market - Global Forecast 2025-2032

 Report
November 2025
197 Pages
Global

From

€3122EUR$3,545USD£2,745GBP

€3469EUR$3,939USD£3,050GBP

Neuroprotection Therapeutics - Global Strategic Business Report

 Report
December 2025
194 Pages
Global

From

€5152EUR$5,850USD£4,529GBP

855 Results (Page 7 of 43)
- 1
- 5
- 6
- 7
- 8
- 9

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.